RPS quits pharmacy body that it helped found in 1912

The Royal Pharmaceutical Society (RPS) has decided “not to renew [its] organisational membership” of the International Pharmaceutical Federation (FIP) this year, over a century after it helped establish it. 

RPS HQ
RPS: Decision to leave FIP will help us “focus on [the] delivery of our mission and vision”

The RPS was one of the founding members of the Netherlands-based global body representing pharmacy in 1912.

In making the decision to leave FIP's network of 140 pharmacy member organisations, the RPS “carefully considered how best to serve [its] members and meet [its] charter obligations”, it said in a statement yesterday (March 17).

The move will help the RPS “focus on [the] delivery of [its] mission and vision” while remaining “outwardly focused and [an] internationally aware organisation”, it wrote.

FIP: RPS’s “regretful” decision

Responding to the news of the RPS’s exit, FIP wrote it was “regretful” the RPS had chosen to so “at a time when global solidarity on issues that affect us all”.

Issues such as “pharmacy workforce capacity, antimicrobial resistance, access to medicines and pharmaceutical care, and sustainability” are affecting sector professionals everywhere, FIP said.

Read more: Updated: RPS could scrap two senior roles in executive team restructure

The organisation did not confirm how much the RPS used to pay for its FIP membership, but said it believes "that the fee would currently be less than a pound per member each year"

It would happily welcome the RPS back into the network should its “circumstances […] change in the future”, it said.

In the meantime, FIP said it will continue to work with its UK members towards securing safe and affordable access to medicines and pharmaceutical care services provided by pharmacists.

RPS to remain "friend" of FIP

The RPS will “remain a friend and supporter” of FIP and recognises “the important role” the global body “plays in pharmacy”, it said.

It pledged to continue being an “active participant in global pharmacy policy” and be “at the forefront of world-wide efforts to reduce antimicrobial resistance, end environmental harm and promote inclusiveness and diversity across the profession”.

But its decision to leave FIP was fiercely questioned by some Twitter users, including former chief pharmaceutical officer for England Keith Ridge, who asked how the RPS could state that it would remain “outwardly focused and internationally aware” without being a FIP member.

Meanwhile, others asked why the RPS had not communicated this decision to its members prior to resolving to leave FIP.

The RPS has recently been in the spotlight for announcing that it could potentially make two senior roles within its executive board redundant as part of a strategy to strengthen the organisation’s “viability”.

Sign in or register for free

Latest from News

Retired pharmacist crushed to death in canal boat accident

 
• By 
 • comment0

Margaret Billings sustained fatal injuries when she was caught between a moving boat and a riverbank during a day out “with family and friends”, an inquest has found.

NHSE scrapped: ‘Fresh start or just more political chaos?’

 
• By 
 • comment3

C+D rounds up some of the immediate pharmacy reaction to news that NHS England will be abolished, with more control moving back to the government and local leaders…

New primary care medical director role as 2-year NHSE axing begins

 
• By 
 • comment3

Wes Streeting has revealed that the DH is “immediately” working to scrap NHS England (NHSE) and put a new “transformation team” in place – adding that it is in the “very final stages” of concluding a new pharmacy contract deal.

More from Business

breaking news

IN FULL: Boots’ parent company sold in $24bn private equity deal

 
• By 
 • comment

Walgreens Boots Alliance (WBA) has “entered into a definitive agreement to be acquired” by private equity firm Sycamore Partners.

Jhoots accounts: Shareholder funds tumble while debts soar

 
• By 
 • comment

Jhoots Chemist’s accounts for 2024 have revealed an almost £2 million year-on-year dip in shareholder funds – as debts to creditors increase more than £2m.